The global women’s health sector could reach $600 billion by 2030, but, when factoring in underdiagnosed conditions and new digital and consumer-directed models, the opportunity could be even larger, according to PwC.
A new analysis (PDF) found the current global market for women’s health is estimated to be between $430 billion and $440 billion, representing a 6% to 8% annual growth rate by 2030.
Moreover, the market for core women’s health—from gynecological conditions to oncology—is currently estimated at $195 billion to $205 billion and projected to reach $270 billion to $280 billion by 2030.
Women’s health currently accounts for approximately 5% of total healthcare research and development and investment funding despite comprising roughly half of the population, researchers said, citing a January 2026 World Economic Forum report.
“The gap is not simply one of equity; it can reflect a structural inefficiency in how healthcare markets have been defined and funded,” the report said.
Researchers say a “broader lens” should be applied when defining women’s health to include conditions unique to women, those that affect women differently and those that disproportionately affect women.
Expanding the definition, according to researchers, not only shows women's necessary lifetime continuity of care but also “reframes women’s health as a longitudinal market opportunity rather than a set of episodic events.”
Between 2020 and 2025, nearly $60 billion was invested across the women’s health sector, per the report. While investments have initially focused on reproductive care, researchers say funding has previously overlooked areas, with women’s oncology and menopause advancing as top areas for growth.
As spending increases, researchers estimate the following growth year over year for respective industries through 2030:
- Consumer technology: 14% to 17% annually
- Pharmaceuticals: 8% to 10% annually
- Payer and employer: 8% to 10% annually
- Provider and care delivery: 5% to 7% annually
- Device and diagnostic: 4% to 6% annually
Researchers note new revenue sources may also be created with better identification of underdiagnosed conditions, scale of digital and artificial-intelligence-enabled models and expanded sex-specific research and development.
“Healthcare leaders who act early can help define the future of women’s health,” the report said. “In doing so, they may unlock one of the more consequential value creation opportunities in modern healthcare.”